Cadomack Pharmaceuticals, founded in 2023, is a forward-thinking private company dedicated to providing high-quality medicines across various therapeutic areas, including Diabetes, Hypertension, Pain Management, and more. Led by a dynamic team of four visionary directors, Cadomack aims to bring world-class pharmaceutical solutions to customers of all scales, from small clinics to large healthcare providers across India. In a short span, the company has built a strong reputation for quality and innovation, with a growing portfolio of over 60 registered brands. Cadomack is on a mission to establish a strong global footprint by consistently delivering products that meet the highest standards. Our state-of-the-art production facilities are ISO, WHO-cGMP, and GLP certified, equipped with modern machinery and cutting-edge technology. At Cadomack, we uphold the highest ethical standards and strive for continuous improvement, ensuring our products exceed industry benchmarks and foster trust among our customers. With a customer-centric approach and a commitment to excellence, Cadomack Pharmaceuticals is poised to become a significant player in the global pharmaceutical landscape.